Search results
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024. 14 new medicines recommended for approval; another 11 medicines recommended for extension of therapeutic indications. 26 July 2024.
The European Medicines Agency (EMA) facilitates development and access to medicines for countries within the European Union (EU). EMA evaluates applications for marketing authorisation submitted via the centralised procedure, monitors the safety of medicines across their lifecycle and provides information to healthcare professionals and patients.
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). It is responsible for the scientific evaluation, supervision and safety monitoring of medicines. EMA Working for every patient in Europe (video in English, with subtitles in 24 different languages) ~ 2 mins
The European Medicines Agency (EMA) protects and promotes human and animal health by evaluating and monitoring medicines within the European Union (EU) and the European Economic Area (EEA).
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency ( EMEA ).
Jun 27, 2024 · Energy Market Authority (EMA) is the government agency that drives the advancement of Singapore's energy future that is resilient, sustainable and competitive.
EMA issues a variety of licences to companies and workers in the electricity and gas industries, companies providing district cooling services to gazetted service areas, and to owners of electrical installations.
The mission of the European Medicines Agency (EMA) is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health in the European Union (EU).
Jun 13, 2024 · EMA is the first regulatory authority worldwide to provide such broad access to clinical data. For more information on the clinical data on this website, see Clinical data available. For more information on EMA and its policy on the publication of clinical data, see the EMA corporate website.
The HMA-EMA Catalogues are repositories of metadata collected from real-world data (RWD) sources and RWD studies. They are intended to help regulators, pharmaceutical companies and researchers to identify and use such data when investigating the use, safety and effectiveness of medicines.
